期刊
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
卷 33, 期 1, 页码 126-129出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/14756366.2017.1404591
关键词
M2 isoform of pyruvate kinase; PKM2 inhibitors; 2,3-didithiocarbamate substituted naphthoquinones; antiproliferative effects
资金
- National Natural Science Foundation of China [81430056, 81372491, 81402777]
- China Postdoctoral Science Foundation [2014M560026, 2015T80028]
The M2 isoform of pyruvate kinase (PKM2) is a potential antitumor therapeutic target. In this study, we designed and synthesised a series of 2, 3-didithiocarbamate substituted naphthoquinones as PKM2 inhibitors based on the lead compound 3k that we previously reported. Among them, compound 3f (IC50 = 1.05 +/- 0.17 mu M) and 3h (IC50 = 0.96 +/- 0.18 mu M) exhibited potent inhibition of PKM2, and their inhibitory activities are superior to compound 3k (IC50 = 2.95 +/- 0.53 mu M) and the known PKM2 inhibitor shikonin (IC50 = 8.82 +/- 2.62 mu M). In addition, we evaluated in vitro antiproliferative effects of target compounds using MTS assay. Most target compounds exhibited dose-dependent cytotoxicity with IC50 values in nanomolar concentrations against HCT116, MCF7, Hela, H1299 and B16 cells. These small molecule PKM2 inhibitors not only provide candidate compounds for cancer therapy, but also offer a tool to probe the biological effects of PKM2 inhibition on cancer cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据